top of page
Pediatric Migraine Studies
We collaborate with companies to bring the latest migraine clinical trials to the Cincinnati area! All studies involve medications that have already received FDA approval in adults with migraine and are now being evaluated in children under the age of 18 years. All study-related costs are fully covered by the sponsoring companies ensuring there are no out-of-pocket expenses for participants.
Abortive Studies
We’re currently enrolling children and teens ages 6 to 17 in research studies focused on treating migraines once they start. These “abortive” oral treatments are taken only when needed—not on a daily basis.
Right now, we’re studying two medications that are already FDA-approved for adults: Reyvow (lasmiditan) and Ubrelvy (ubrogepant), to see how well they work for pediatric patients who have fewer than 15 headache days per month.
All of our studies are officially listed on ClinicalTrials.gov, a trusted source for clinical research information.
Learn more about these studies:
bottom of page